Author:
Wang Kui-Rong,Jiang Tao,Wu Ting-Ting,Zhou Shui-Hong,Yao Hong-Tian,Wang Qin-Ying,Lu Zhong-Jie
Abstract
Abstract
Background
The etiology of inflammatory myofibroblastic tumors (IMTs) is controversial and the prognosis is unpredictable. Previous studies have not investigated the expression of hypoxia-related markers in IMTs.
Methods
Between 2002 and 2012, 12 consecutive patients with histologically proven IMTs were enrolled in the study. Immunohistochemistry was used to detect GLUT-1, HIF-1α, PI3K, and p-Akt expression in paraffin-embedded tumor specimens. Associations among GLUT-1, HIF-1α, PI3K, and p-Akt protein expression and clinical parameters were investigated.
Results
The mean duration of follow-up was 52.1 months (range, 11 to 132 months). Six patients had local recurrence. GLUT-1, HIF-1α, PI3K, and p-Akt expression were detected in 41.7%, 50.0%, 33.3%, and 41.7% of patients, respectively. Fisher’s exact test revealed significant correlations between recurrence of IMT and PI3K expression (P = 0.01) and p-Akt expression (P = 0.015). Univariate analyses revealed significant correlations between survival and GLUT-1 expression (P = 0.028), PI3K expression (P = 0.006), and p-Akt expression (P = 0.028). Multivariate analysis did not show a significant relationship between survival and GLUT-1, HIF-1α, PI3K, or p-Akt. Spearman rank correlation analysis showed significant correlations between HIF-1α and PI3K expression (r = 0.707, P = 0.01) and between p-Akt and PI3K expression (r = 0.837, P = 0.001).
Conclusions
Although our results are inconclusive owing to the small sample size, they suggest that PI3K and p-Akt expression may play a role in the recurrence of IMTs of the head and neck.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Fletcher CDM, Unni KK, Mertens F: World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Soft Tissues and Bone. 2002, Lyon: IARC Press, 91-93.
2. Ong HS, Ji T, Zhang CP, Li J, Wang LZ, Li RR, Sun J, Ma CY: Head and neck inflammatory myofibroblastic tumor (IMT): evaluation of clinicopathologic and prognostic features. Oral Oncol. 2012, 48: 141-148. 10.1016/j.oraloncology.2011.09.004.
3. Jiang YH, Cheng B, Ge MH, Cheng Y, Zhang G: Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastictumours. J Int Med Res. 2009, 37: 867-877. 10.1177/147323000903700332.
4. Coffin CM, Hornick JL, Fletcher CD: Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J SurgPathol. 2007, 31: 509-520.
5. Lacoste L, Galant C, Gigot JF, Lacoste B, Annet L: Inflammatory myofibroblastic tumor of the pancreatic head. JBR-BTR. 2012, 95: 267-269.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献